Hicipro M 500mg/300mg Tablet
By Hicipro M
Rx
10 Tablet in a Strip

Composition
Ciprofloxacin(500mg) + Metronidazole(300mg)

Manufacturer - The Pharmed Research Lab Pvt Ltd
Plot No. 200A, Kishanpur, Roorkee, 247667 (U.K)

Expires on or after
October, 2025

liver
Hicipro M 500mg/300mg Tablet is considered safe for use in individuals with liver disease. It has been observed that there may not be a requirement for dose adjustment in such patients based on the limited available data. However, it is strongly advised to consult your doctor before starting the medication. In case you notice any symptoms indicative of liver issues such as jaundice (yellowing of eyes and skin), itching, or clay-colored stools while on this medication, inform your healthcare provider promptly.

kidney
Hicipro M 500mg/300mg Tablet requires caution in kidney disease patients. Dosage adjustment may be necessary. Consult your doctor regarding kidney issues with Hicipro M 500mg/300mg Tablet.

alcohol
Caution should be taken when consuming alcohol while on Hicipro M 500mg/300mg Tablet as it may result in symptoms like flushing, increased heart rate, nausea, thirst, chest pain, and low blood pressure.

driving
When taking Hicipro M 500mg/300mg Tablet, be cautious when driving as it may cause drowsiness, dizziness, confusion, hallucinations, seizures, or vision issues that can impair driving ability.

pregnancy
Hicipro M 500mg/300mg Tablet may not be safe during pregnancy, as animal studies suggest potential harm to the baby. Your doctor will evaluate risks and benefits before prescribing. Please consult your doctor.

breastfeeding
Hicipro M 500mg/300mg Tablet is likely safe during breastfeeding. Limited data indicates minimal risk to the baby. Monitor the baby for fever, loss of appetite, or diarrhea, and inform your doctor promptly if these occur.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | GASTRO INTESTINAL |
Action Class | - |
₹67.5
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 11-Feb-2025